Clinical Trials Browser

OTHER × flumatinib × Other hematologic neoplasm × Clear all

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05433532 2024-04-25

Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients

LymphoidMyeloidOther hematologic neoplasm

Philadelphia Chromosome, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04375683 2022-03-24

Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL

Phase 3 Unknown

28 enrolled

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04677439 2022-03-16

Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure

Phase 4 Unknown

200 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Clinical Trials

Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL

Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients

Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL

Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure